AKER BIOMARINE HUMAN INGREDIENTS AS: årsregnskap 2023 vs 2022
Grew 2476% on revenue, stronger earnings, fresh owner capital
approved 2024-08-20; registry 2024-09-02; journal 2024 738360
Summary
What changed
Comparing Årsregnskap 2023 with 2022 for AKER BIOMARINE HUMAN INGREDIENTS AS. Revenue 412 NOK → 10.6k NOK (+2476.5%). Net result 0 NOK → +5.44m NOK. Equity 0 NOK → 7.31m NOK.
On the constructive side: revenue rose; operating result improved; net result improved.
Also worth watching: thin equity buffer; book investments changed. All figures are taken from the published annual accounts for AKER BIOMARINE HUMAN INGREDIENTS AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 412 NOK to 10.6k NOK (+2476.5% YoY). Calculated
-
↑
Operating result improved
Operating result +456 NOK → +5 911 NOK (op. margin 110.7% → 55.7%). Calculated
-
↑
Net result improved
Net result 0 NOK → +5.44m NOK (net margin 0.0% → 51251.2%). Calculated
-
↑
Equity strengthened
Book equity 0 NOK → 7.31m NOK. Calculated
-
↑
Owners injected capital
Paid-in equity rose 364 NOK → 2 520 NOK (+2 156 NOK). Reported fact
Things to notice
-
·
Thin equity buffer
Equity ratio is 6.4% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation
-
·
Book investments changed
Investment / intangible book value 64 NOK → 4 107 NOK. Reported fact